3D bioprinting technologies hold huge potential to transform patient care and treatment, delivering the next generation of personalised medicine. But current legislative boundaries are poorly defined, and the pathways to approval are unclear, creating unnecessary delays and costs in getting these new technologies to patients. Here, Dr Marco Domingos from the Bioprinting Technology Platform argues […]